ckd semaglutide just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Semaglutide: A Breakthrough for Chronic

The FDA also recommends examining hard clinical endpoints such hepatic decompensations, transplant free survival, and all-cause mortality, although these results are not necessarily needed prior to drug approval given the long length of follow up potentially required

Asian Pacific journal of tropical biomedicine, 3 (4), 253266

Inspect the vial immediately

In the United States, regulatory oversight from the FDA and consumer protection from the FTC place similar expectations on the separation between factual reporting and promotional content

Our providers will create a custom weight loss plan tailored to your specific needs and preferences